A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. Article uri icon

Overview

publication date

  • July 30, 2019

Research

keywords

  • Interferon-alpha
  • Mesenteric Veins
  • Polycythemia Vera
  • Polyethylene Glycols
  • Thrombocythemia, Essential
  • Venous Thrombosis

Identity

PubMed Central ID

  • PMC6884668

Scopus Document Identifier

  • 85069946674

Digital Object Identifier (DOI)

  • 10.1038/s41375-019-0524-7

PubMed ID

  • 31363161

Additional Document Info

volume

  • 33

issue

  • 12